Myocarditis With COVID-19 mRNA Vaccines
2021/07/20 by Biykem Bozkurt, Ishan Kamat, Peter J. Hotez · 33 citations
Medicine · #SARS-CoV-2 and COVID-19 Research #Viral Infections and Immunology Research #Heparin-Induced Thrombocytopenia and Thrombosis
paper · pdf · doi:10.1161/circulationaha.121.056135
Abstract
Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) mRNA vaccinations, especially in young adult and adolescent males. According to the US Centers for Disease Control and Prevention, myocarditis/pericarditis rates are ≈12.6 cases per million doses of second-dose mRNA vaccine among individuals 12 to 39 years of age. In reported cases, patients with myocarditis invariably presented with chest pain, usually 2 to 3 days after a second dose of mRNA vaccination, and had elevated cardiac troponin levels. ECG was abnormal with ST elevations in most, and cardiac MRI was suggestive of myocarditis in all tested patients. There was no evidence of acute COVID-19 or other viral infections. In 1 case, a cardiomyopathy gene panel was negative, but autoantibody levels against certain self-antigens and frequency of natural killer cells were increased. Although the mechanisms for development of myocarditis are not clear, molecular mimicry between the spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and self-antigens, trigger of preexisting dysregulated immune pathways in certain individuals, immune response to mRNA, and activation of immunologic pathways, and dysregulated cytokine expression have been proposed. The reasons for male predominance in myocarditis cases are unknown, but possible explanations relate to sex hormone differences in immune response and myocarditis, and also underdiagnosis of cardiac disease in women. Almost all patients had resolution of symptoms and signs and improvement in diagnostic markers and imaging with or without treatment. Despite rare cases of myocarditis, the benefit-risk assessment for COVID-19 vaccination shows a favorable balance for all age and sex groups; therefore, COVID-19 vaccination is recommended for everyone ≥12 years of age.
Cited by
- Acute anaphylactic and multiorgan inflammatory effects of Comirnaty in pigs: evidence of spike protein mRNA transfection and paralleling inflammatory cytokine upregulation
- Sex differences in adverse drug reactions: Are women more impacted?
- Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies
- Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex
- Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis
- Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning
- Global vaccine development
- 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play
- Cardiac involvement in the long-term implications of COVID-19. [europepmc]
- COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety. [europepmc]
- Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types. [europepmc]
- Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. [europepmc]
- Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine : A Case-Control Study. [europepmc]
- Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. [europepmc]
- Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine. [europepmc]
- 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee. [europepmc]
- Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis. [europepmc]
- Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. [europepmc]
- COVID-19 Vaccination Hesitancy among Healthcare Workers-A Review. [europepmc]
- Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines. [europepmc]
- Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review. [europepmc]
- Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex. [europepmc]
- Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents. [europepmc]
- Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis. [europepmc]
- Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis. [europepmc]
- COVID-19 vaccines adverse events: potential molecular mechanisms. [europepmc]
- Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis. [europepmc]
- Association of COVID-19 with Comorbidities: An Update. [europepmc]
- Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications. [europepmc]
- Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis. [europepmc]
- COVID-19, Myocarditis and Pericarditis. [europepmc]
- Apparent Risks of Postural Orthostatic Tachycardia Syndrome Diagnoses After COVID-19 Vaccination and SARS-Cov-2 Infection. [europepmc]
- Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study. [europepmc]
Related